BPL-003 Efficacy and Safety in Treatment Resistant Depression

PHASE2CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

September 14, 2023

Primary Completion Date

March 28, 2025

Study Completion Date

July 3, 2025

Conditions
Treatment Resistant Depression
Interventions
DRUG

BPL-003

A single dose administered intranasally

DRUG

BPL-003

A single dose administered intranasally (administered as 2 nasal sprays minutes apart)

Trial Locations (42)

2050

Royal Prince Alfred Hospital, Sydney

3050

Royal Melbourne Hospital, University of Melbourne, Parkville

3053

NeuroCentrix Research, Melbourne

3168

Dept. of Psychiatry and School Psychological Sciences, Monash University, Clayton

10032

New York State Psychiatric Institute, New York

10117

Charité - Universitätsmedizin Berlin, Berlin

10247

OVID Clinic, Augmented Psychotherapy, Berlin

20850

Sunstone Medical PC (Sunstone Therapies / Aquilino Cancer Center), Rockville

28050

Fundación de Investigación HM Hospital, Madrid

30030

CenExel iResearch, Decatur

30329

Emory University, Brain Health Center, Department of Psychiatry and Behavioral Sciences, Atlanta

30331

CenExel ACMR, Atlanta

33011

Centro de Salud Mental La Corredoria, Oviedo

33319

Segal Trials Center for Psychedelic and Cannabis Research, Lauderhill

35209

UAB School of Public Health, Department of Health Behavior, Birmingham

37005

Centro Salud San Juan, Salamanca

53705

University of Wisconsin, Dept of Family Medicine & Community Health, Madison

60528

Department of Psychiatry, University Hospital Frankfurt, Frankfurt am Main

68159

Central Institute of Mental Health, Dept. of Molecular Neuroimaging, Mannheim

72076

Universitätsklinik für Psychiatrie und Psychotherapie, Calwerstr. 14, Tübingen

72758

Woodland Research Northwest, Rogers

75093

AIM Trials, Plano

75115

Insite clinical research, DeSoto

80525

Wholeness Center, Fort Collins

84020

Cedar Clinical Research, Draper

90404

Pacific Neuroscience Institute, Treatment and Research in Psychedelics (TRIP) Program, Santa Monica

92037

Kadima Neuropsychiatry Institute, San Diego

94114

San Francisco Insight and Integration Center, San Francisco

97227

Portland Psychotherapy, Portland

02131

Boston Clinical Trials, Boston

08009

CenExel HRI, Berlin

80-214

Department of Psychiatry, UCK, Gdansk

80-546

Centrum Badań Klinicznych PI-House sp. z o.o., Gdansk

92-216

SPZOZ Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi, Lodz

95-080

Klinika Inventiva, Tuszyn

02-957

Department of Pharmacology and Physiology of CNS, Warsaw

08003

Hospital del Mar, Barcelona

08029

Parc Sanitari Sant Joan de Deu HD Numancia, Barcelona

08036

Hospital Clinic de Barcelona, Psychiatry and Psychology Dept., Barcelona

EX2 5DW

NIHR Exeter Clinical Research Facility, Exeter

SE5 8AF

King's College London - Institute of Psychiatry, Psychology & Neuroscience (IoPPN) - Centre for Affective Disorders (CfAD), London

W1G 8DR

Clerkenwell Health, London

Sponsors
All Listed Sponsors
lead

Beckley Psytech Limited

INDUSTRY

NCT05870540 - BPL-003 Efficacy and Safety in Treatment Resistant Depression | Biotech Hunter | Biotech Hunter